Table 1 Clinical characteristics of the subjects
Group | P value | |||||||
|---|---|---|---|---|---|---|---|---|
A | B | C | D | E | F | |||
Number | 21 | 22 | 23 | 35 | 30 | 42 | ||
Age | years | 43.5 41.50–46.50 | 47 44.50–49.00 | 47* 46.00–49.00 | 49* 46.50–50.50 | 51* 49.50–53.00 | 53* 51.75-54.00 | < 0.001 |
Height | cm | 155.0 152.25–157.00 | 158.0 154.00-160.85 | 160.4 158.93–163.00 | 158.7 156.63–160.00 | 158.0 154.00-160.00 | 156.5 155.00-159.05 | 0.189 |
Weight | kg | 50.1 47.70-56.25 | 55.9 50.5-57.65 | 56.0 52.65–58.53 | 59.0 52.00-61.20 | 52.0 49.40–57.40 | 53.1 50.00-57.15 | 0.182 |
BMI | kg/cm² | 20.1 19.50–21.50 | 21.4 20.00-23.55 | 21.8 20.51–23.13 | 22.5 20.31-25.00 | 21.9 20.09–22.79 | 21.7 20.30-23.53 | 0.379 |
LH | mIU/ml | 3.7 2.83- 5.90 | 7.2 4.05–13.28 | 8.8 7.7- 26.3 | 30.05* 17.48- 35.78 | 33.30* 20.80- 43.90 | 30.55* 23.5- 38.48 | < 0.001 |
FSH | mIU/ml | 5.6 4.80- 8.00 | 14.05 11.15- 35.18 | 23.9 13.5- 42.9 | 56.95* 30.55- 87.35 | 93.40* 70.70- 110.0 | 95.85* 71.43- 123.70 | < 0.001 |
testosterone | ng/ml | 0.26 0.17–0.43 | 0.15 0.11–0.27 | 0.28 0.24- 0.36 | 0.22 0.18- 0.33 | 0.21 0.13- 0.29 | 0.17 0.09- 0.27 | |
Free testosterone | pg/ml | 0.20 0.13–0.83 | 0.22 0.09- 055 | 0.88 0.32- 0.9 | 0.27 0.17- 0.54 | 0.21 0.15- 0.50 | 0.12 0.08- 0.33 | |
DHEAS | µg/ml | 119.5 80.5- 171.5 | 71 75.5- 163 | 180 100- 233.5 | 105.5 94- 199.5 | 113.5 73.8- 163 | 114 65.5- 148.5 | |
androstenedione | ng/ml | 2.95 0.94- 2.00 | 0.6 0.58- 1.17 | 1.32 0.96- 1.52 | 1.09 0.69- 1.09 | 0.82 0.6- 1.05 | 0.79 0.43- 0.86 | |
androstenediol | ng/ml | 0.54 0.33–0.71 | 0.25 0.22- 0.44 | 0.42 0.36- 0.55 | 0.33 0.35- 0.61 | 0.35 0.28- 0.56 | 0.55 0.25- 0.51 | |
estradiol | pg/ml | 126.5 85.5-176.5 | 70 39- 115.5 | 64 45.5- 91.5 | 43.5 27.3- 85 | 12.5 5.0- 29 | 12.5 5.0- 34.5 | |
estrone | pg/ml | 69.85 45.1-119.2 | 23.1 25.3- 74.5 | 58.1 32.4- 66.6 | 26.5 20.3- 49.9 | 16.6 13.5- 24 | 17 12.5- 21.3 | |